2026 Q3 Portfolio Activity
In 2026 Q3, PSP Research LLC maintained a portfolio of 76 distinct positions. The most significant new addition was SERA PROGNOSTICS INC, now representing 3.43% of the total fund value. The fund also reduced its exposure to SPDR SERIES TRUST by 32.2%.
Position History
hover any row below to update
Loading…
Total Positions
76
Quarter
2026 Q3
Top Holding
SGOV (48.3%)
Top 10 Concentration
95.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 76
PSP Research LLC Full Holdings List — 2026 Q3
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
SGOV
ISHARES TR
|
ETF | 48.33% | 37.51% |
#1
1
Prev: #2
|
7.0 |
—
|
no change | no change |
P
S
|
700,000 | $70,476,000 |
$97.74
+2.9%
|
2025 Q4 | 13F Filing | 2026-09-30 | 2026-10-21 | ||
|
XBI
SPDR SERIES TRU...
|
Unknown | 41.79% | 48.01% |
#2
1
Prev: #1
|
5.5 |
—
|
-183,500 | -32.2% |
P
S
|
386,500 | $60,943,320 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-10-21 | |||
|
SERA
SERA PROGNOSTIC...
|
Healthcare | 3.43% | — |
#3
Prev: #—
|
5.9 |
—
|
2,396,685 | — |
NEW
|
2,396,685 | $5,009,072 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-10-21 | |||
|
HALO
HALOZYME THERAP...
|
Healthcare | 0.23% | 0.29% |
#4
9
Prev: #13
|
0.6 |
—
|
-4,000 | -57.1% |
P
S
|
3,000 | $331,200 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-10-21 | |||
|
MDGL
MADRIGAL PHARMA...
|
Healthcare | 0.21% | 0.17% |
#5
39
Prev: #44
|
1.6 |
—
|
no change | no change |
P
S
|
600 | $302,376 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-10-21 | |||
|
EXEL
EXELIXIS INC
|
Healthcare | 0.20% | 0.23% |
#6
25
Prev: #31
|
0.1 |
—
|
-3,000 | -37.5% |
P
S
|
5,000 | $292,050 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-10-21 | |||
|
RPRX
ROYALTY PHARMA ...
|
Healthcare | 0.20% | 0.33% |
#7
4
Prev: #3
|
0.1 |
—
|
-6,000 | -54.5% |
P
S
|
5,000 | $291,800 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-10-21 | |||
|
ARGX
ARGENX SE
|
Healthcare | 0.20% | 0.32% |
#8
2
Prev: #6
|
0.1 |
—
|
-341 | -53.2% |
P
S
|
300 | $287,673 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-10-21 | |||
|
NRIX
NURIX THERAPEUT...
|
Healthcare | 0.20% | 0.32% |
#9
5
Prev: #4
|
0.1 |
—
|
-13,000 | -52.0% |
P
S
|
12,000 | $284,520 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-10-21 | |||
|
TGTX
TG THERAPEUTICS...
|
Healthcare | 0.19% | 0.29% |
#10
2
Prev: #12
|
0.1 |
—
|
-5,000 | -50.0% |
P
S
|
5,000 | $278,900 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-10-21 | |||
|
TARS
TARSUS PHARMACE...
|
Healthcare | 0.19% | 0.23% |
#11
18
Prev: #29
|
0.1 |
—
|
-3,500 | -50.0% |
P
S
|
3,500 | $275,135 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-10-21 | |||
|
HRMY
HARMONY BIOSCIE...
|
Healthcare | 0.19% | 0.19% |
#12
28
Prev: #40
|
0.1 |
—
|
-3,000 | -30.0% |
P
S
|
7,000 | $274,820 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-10-21 | |||
|
ARQT
ARCUTIS BIOTHER...
|
Healthcare | 0.18% | 0.27% |
#13
3
Prev: #16
|
0.1 |
—
|
-9,700 | -49.2% |
P
S
|
10,000 | $264,300 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-10-21 | |||
|
KNSA
KINIKSA PHARMAC...
|
Healthcare | 0.18% | 0.17% |
#14
31
Prev: #45
|
0.1 |
—
|
-1,500 | -30.0% |
P
S
|
3,500 | $261,135 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-10-21 | |||
|
SUPN
SUPERNUS PHARMA...
|
Healthcare | 0.18% | 0.15% |
#15
37
Prev: #52
|
1.1 |
—
|
no change | no change |
P
S
|
6,000 | $258,240 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-10-21 | |||
|
IMNM
IMMUNOME INC
|
Healthcare | 0.18% | 0.20% |
#16
22
Prev: #38
|
0.1 |
—
|
-6,000 | -33.3% |
P
S
|
12,000 | $258,120 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-10-21 | |||
|
NBIX
NEUROCRINE BIOS...
|
Healthcare | 0.18% | 0.27% |
#17
1
Prev: #18
|
0.1 |
—
|
-1,200 | -40.0% |
P
S
|
1,800 | $255,312 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-10-21 | |||
|
ORKA
ORUKA THERAPEUT...
|
Healthcare | 0.17% | 0.15% |
#18
33
Prev: #51
|
1.1 |
—
|
no change | no change |
P
S
|
3,000 | $249,870 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-10-21 | |||
|
TNGX
TANGO THERAPEUT...
|
Healthcare | 0.17% | 0.17% |
#19
28
Prev: #47
|
1.1 |
—
|
no change | no change |
P
S
|
10,000 | $249,500 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-10-21 | |||
|
DFTX
DEFINIUM THERAP...
|
Healthcare | 0.17% | 0.25% |
#20
4
Prev: #24
|
0.1 |
—
|
-3,500 | -35.0% |
P
S
|
6,500 | $247,390 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-10-21 | |||
|
RVMD
REVOLUTION MEDI...
|
Healthcare | 0.17% | 0.12% |
#21
42
Prev: #63
|
1.1 |
—
|
no change | no change |
P
S
|
1,200 | $246,312 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-10-21 | |||
|
ALKS
ALKERMES PLC
|
Healthcare | 0.17% | 0.17% |
#22
24
Prev: #46
|
1.1 |
—
|
no change | no change |
P
S
|
6,000 | $243,120 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-10-21 | |||
|
AUPH
AURINIA PHARMAC...
|
Healthcare | 0.17% | 0.27% |
#23
6
Prev: #17
|
0.1 |
—
|
-15,000 | -50.0% |
P
S
|
15,000 | $242,925 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-10-21 | |||
|
INCY
INCYTE CORP
|
Healthcare | 0.17% | 0.32% |
#24
19
Prev: #5
|
0.1 |
—
|
-3,300 | -62.3% |
P
S
|
2,000 | $242,700 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-10-21 | |||
|
NTLA
INTELLIA THERAP...
|
Healthcare | 0.17% | 0.18% |
#25
18
Prev: #43
|
1.1 |
—
|
no change | no change |
P
S
|
20,000 | $241,200 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-10-21 | |||
|
IMVT
IMMUNOVANT INC
|
Healthcare | 0.16% | 0.27% |
#26
7
Prev: #19
|
0.1 |
—
|
-6,000 | -46.2% |
P
S
|
7,000 | $236,460 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-10-21 | |||
|
STOK
STOKE THERAPEUT...
|
Healthcare | 0.16% | 0.21% |
#27
9
Prev: #36
|
0.1 |
—
|
-3,000 | -25.0% |
P
S
|
9,000 | $234,000 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-10-21 | |||
|
KRYS
KRYSTAL BIOTECH...
|
Healthcare | 0.16% | 0.14% |
#28
27
Prev: #55
|
1.1 |
—
|
no change | no change |
P
S
|
692 | $230,132 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-10-21 | |||
|
ASND
ASCENDIS PHARMA...
|
Healthcare | 0.16% | 0.21% |
#29
5
Prev: #34
|
0.1 |
—
|
-500 | -33.3% |
P
S
|
1,000 | $227,830 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-10-21 | |||
|
SNDX
SYNDAX PHARMACE...
|
Healthcare | 0.15% | 0.23% |
#30
Prev: #30
|
0.1 |
—
|
-8,000 | -40.0% |
P
S
|
12,000 | $225,600 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-10-21 | |||
|
KYMR
KYMERA THERAPEU...
|
Healthcare | 0.15% | 0.24% |
#31
5
Prev: #26
|
0.1 |
—
|
-2,000 | -50.0% |
P
S
|
2,000 | $223,580 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-10-21 | |||
|
DNTH
DIANTHUS THERAP...
|
Healthcare | 0.15% | 0.13% |
#32
28
Prev: #60
|
1.1 |
—
|
no change | no change |
P
S
|
2,500 | $220,125 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-10-21 | |||
|
TRVI
TREVI THERAPEUT...
|
Healthcare | 0.15% | 0.30% |
#33
23
Prev: #10
|
0.1 |
—
|
-15,000 | -50.0% |
P
S
|
15,000 | $214,800 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-10-21 | |||
|
MIRM
MIRUM PHARMACEU...
|
Healthcare | 0.15% | 0.16% |
#34
16
Prev: #50
|
1.1 |
—
|
no change | no change |
P
S
|
2,500 | $213,700 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-10-21 | |||
|
IMCR
IMMUNOCORE HLDG...
|
Healthcare | 0.15% | 0.26% |
#35
12
Prev: #23
|
0.1 |
—
|
-8,141 | -53.8% |
P
S
|
7,000 | $212,030 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-10-21 | |||
|
PTGX
PROTAGONIST THE...
|
Healthcare | 0.14% | 0.20% |
#36
3
Prev: #39
|
0.1 |
—
|
-1,500 | -50.0% |
P
S
|
1,500 | $211,335 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-10-21 | |||
|
EWTX
EDGEWISE THERAP...
|
Healthcare | 0.14% | 0.11% |
#37
32
Prev: #69
|
1.1 |
—
|
no change | no change |
P
S
|
5,000 | $203,000 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-10-21 | |||
|
ORIC
ORIC PHARMACEUT...
|
Healthcare | 0.12% | 0.07% |
#38
36
Prev: #74
|
1.0 |
—
|
no change | no change |
P
S
|
13,000 | $175,110 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-10-21 | |||
|
DYN
DYNE THERAPEUTI...
|
Healthcare | 0.11% | 0.24% |
#39
12
Prev: #27
|
0.0 |
—
|
-10,000 | -50.0% |
P
S
|
10,000 | $161,100 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-10-21 | |||
|
CMPS
COMPASS PATHWAY...
|
Healthcare | 0.09% | 0.14% |
#40
16
Prev: #56
|
0.0 |
—
|
-8,000 | -44.4% |
P
S
|
10,000 | $124,400 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-10-21 | |||
|
OCUL
OCULAR THERAPEU...
|
Healthcare | 0.08% | 0.08% |
#41
31
Prev: #72
|
1.0 |
—
|
no change | no change |
P
S
|
15,000 | $115,050 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-10-21 | |||
|
CTMX
CYTOMX THERAPEU...
|
Healthcare | 0.07% | 0.08% |
#42
29
Prev: #71
|
1.0 |
—
|
no change | no change |
P
S
|
39,400 | $107,168 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-10-21 | |||
|
ARDX
ARDELYX INC
|
Healthcare | 0.07% | 0.16% |
#43
5
Prev: #48
|
0.0 |
—
|
-30,000 | -50.0% |
P
S
|
30,000 | $102,600 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-10-21 | |||
|
OLMA
OLEMA PHARMACEU...
|
Healthcare | 0.06% | 0.07% |
#44
31
Prev: #75
|
1.0 |
—
|
no change | no change |
P
S
|
10,000 | $86,400 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-10-21 | |||
|
EYPT
EYEPOINT INC
|
Healthcare | 0.00% | 0.08% |
Sold All 😨
(Was: #73) |
0.0 |
—
|
-10,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-10-21 | |||
|
AMLX
AMYLYX PHARMACE...
|
Healthcare | 0.00% | 0.10% |
Sold All 😨
(Was: #70) |
0.0 |
—
|
-10,838 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-10-21 | |||
|
SRRK
SCHOLAR ROCK HL...
|
Healthcare | 0.00% | 0.11% |
Sold All 😨
(Was: #68) |
0.0 |
—
|
-3,827 | -100.0% |
CLOSED
|
— | $— | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-10-21 | |||
|
ARWR
ARROWHEAD PHARM...
|
Healthcare | 0.00% | 0.11% |
Sold All 😨
(Was: #67) |
0.0 |
—
|
-2,600 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-10-21 | |||
|
DNLI
DENALI THERAPEU...
|
Healthcare | 0.00% | 0.12% |
Sold All 😨
(Was: #66) |
0.0 |
—
|
-8,463 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-10-21 | |||
|
RYTM
RHYTHM PHARMACE...
|
Healthcare | 0.00% | 0.12% |
Sold All 😨
(Was: #65) |
0.0 |
—
|
-2,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-10-21 |
Showing 1-50 of 76 holdings